INDAPTUS THERAPEUTICS INC (INDP) Fundamental Analysis & Valuation

NASDAQ:INDP • US45339J2042

Current stock price

2.11 USD
+0.26 (+14.05%)
At close:
1.99 USD
-0.12 (-5.69%)
After Hours:

This INDP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. INDP Profitability Analysis

1.1 Basic Checks

  • INDP had negative earnings in the past year.
  • INDP had a negative operating cash flow in the past year.
  • In the past 5 years INDP always reported negative net income.
  • In the past 5 years INDP always reported negative operating cash flow.
INDP Yearly Net Income VS EBIT VS OCF VS FCFINDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • INDP's Return On Assets of -223.94% is on the low side compared to the rest of the industry. INDP is outperformed by 90.52% of its industry peers.
  • With a Return On Equity value of -661.53%, INDP is not doing good in the industry: 79.69% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -223.94%
ROE -661.53%
ROIC N/A
ROA(3y)-177.33%
ROA(5y)-120.4%
ROE(3y)-390.01%
ROE(5y)-249.93%
ROIC(3y)N/A
ROIC(5y)N/A
INDP Yearly ROA, ROE, ROICINDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for INDP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INDP Yearly Profit, Operating, Gross MarginsINDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. INDP Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for INDP has been increased compared to 1 year ago.
  • The number of shares outstanding for INDP has been increased compared to 5 years ago.
  • There is no outstanding debt for INDP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INDP Yearly Shares OutstandingINDP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
INDP Yearly Total Debt VS Total AssetsINDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -18.44, we must say that INDP is in the distress zone and has some risk of bankruptcy.
  • INDP has a worse Altman-Z score (-18.44) than 82.59% of its industry peers.
  • INDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.44
ROIC/WACCN/A
WACCN/A
INDP Yearly LT Debt VS Equity VS FCFINDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that INDP should not have too much problems paying its short term obligations.
  • INDP has a Current ratio of 1.51. This is amonst the worse of the industry: INDP underperforms 82.20% of its industry peers.
  • A Quick Ratio of 1.51 indicates that INDP should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.51, INDP is doing worse than 80.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
INDP Yearly Current Assets VS Current LiabilitesINDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. INDP Growth Analysis

3.1 Past

  • INDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.69%, which is quite impressive.
EPS 1Y (TTM)43.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • INDP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.67% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y74.32%
EPS Next 2Y34.95%
EPS Next 3Y26.83%
EPS Next 5Y17.67%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
INDP Yearly Revenue VS EstimatesINDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2019 2028 2029 2030 2031 2032 100M 200M 300M 400M
INDP Yearly EPS VS EstimatesINDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -1K -2K -3K

More info and screens

Find the best growth stocksShow best growing peers

1

4. INDP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for INDP. In the last year negative earnings were reported.
  • Also next year INDP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INDP Price Earnings VS Forward Price EarningsINDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INDP Per share dataINDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20 -25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as INDP's earnings are expected to grow with 26.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.95%
EPS Next 3Y26.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INDP Dividend Analysis

5.1 Amount

  • No dividends for INDP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INDP Fundamentals: All Metrics, Ratios and Statistics

INDAPTUS THERAPEUTICS INC

NASDAQ:INDP (4/10/2026, 8:00:02 PM)

After market: 1.99 -0.12 (-5.69%)

2.11

+0.26 (+14.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17
Earnings (Next)05-12
Inst Owners4.5%
Inst Owner Change0%
Ins Owners18.31%
Ins Owner Change0.03%
Market Cap4.73M
Revenue(TTM)N/A
Net Income(TTM)-20.85M
Analysts82.86
Price Target10.2 (383.41%)
Short Float %0.63%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.26%
Min EPS beat(2)-1.41%
Max EPS beat(2)29.94%
EPS beat(4)2
Avg EPS beat(4)-10.55%
Min EPS beat(4)-74.29%
Max EPS beat(4)29.94%
EPS beat(8)6
Avg EPS beat(8)5.45%
EPS beat(12)10
Avg EPS beat(12)10.17%
EPS beat(16)14
Avg EPS beat(16)13.69%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-25.54
EYN/A
EPS(NY)-6.56
Fwd EYN/A
FCF(TTM)-6.62
FCFYN/A
OCF(TTM)-6.62
OCFYN/A
SpS0
BVpS1.41
TBVpS1.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -223.94%
ROE -661.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-177.33%
ROA(5y)-120.4%
ROE(3y)-390.01%
ROE(5y)-249.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z -18.44
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.61%
EPS Next Y74.32%
EPS Next 2Y34.95%
EPS Next 3Y26.83%
EPS Next 5Y17.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.29%
OCF growth 3YN/A
OCF growth 5YN/A

INDAPTUS THERAPEUTICS INC / INDP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INDAPTUS THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 2 / 10 to INDP.


What is the valuation status for INDP stock?

ChartMill assigns a valuation rating of 1 / 10 to INDAPTUS THERAPEUTICS INC (INDP). This can be considered as Overvalued.


What is the profitability of INDP stock?

INDAPTUS THERAPEUTICS INC (INDP) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for INDP stock?

The Earnings per Share (EPS) of INDAPTUS THERAPEUTICS INC (INDP) is expected to grow by 74.32% in the next year.